OGN
Organon & Co.
NYSE · USHealthcareDrug Manufacturers - General
$13.49-0.22%
Price as of Jul 20, 2026
OGN valuation
Organon & Co. valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- 3.64x
- P/E 2026E
- 3.87x
- P/E 2027E
- 3.64x
- P/E 2028E
- 3.42x
- P/S forward
- 0.57x
Trailing multiples
- P/E TTM
- 14.20x
- PEG TTM
- 0.05x
- Price / book
- 3.92x
- Price / sales
- 0.57x
- Price / cash flow
- 4.17x
Enterprise value
- Enterprise value
- $11.0B
- EV / sales
- 1.78x
- EV / EBITDA
- 7.95x
- EV / EBIT
- 9.28x
- Market cap
- $3.5B
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.